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The heterodimeric complex ERCC1-XPF is a struc-
ture-specific endonuclease responsible for the 5* inci-
sion during mammalian nucleotide excision repair
(NER). Additionally, ERCC1-XPF is thought to function
in the repair of interstrand DNA cross-links and, by
analogy to the homologous Rad1-Rad10 complex in Sac-
charomyces cerevisiae, in recombination between direct
repeated DNA sequences. To gain insight into the role of
ERCC1-XPF in such recombinational processes and in
the NER reaction, we studied in detail the DNA struc-
tural elements required for ERCC1-XPF endonucleo-
lytic activity. Recombinant ERCC1-XPF, purified from
insect cells, was found to cleave stem-loop substrates at
the DNA junction in the absence of other proteins like
replication protein A, showing that the structure-spe-
cific endonuclease activity is intrinsic to the complex.
Cleavage depended on the presence of divalent cations
and was optimal in low Mn21 concentrations (0.2 mM). A
minimum of 4–8 unpaired nucleotides was required for
incisions by ERCC1-XPF. Splayed arm and flap sub-
strates were also cut by ERCC1-XPF, resulting in the
removal of 3* protruding single-stranded arms. All inci-
sions occurred in one strand of duplex DNA at the 5* side
of a junction with single-stranded DNA. The exact cleav-
age position varied from 2 to 8 nucleotides away from
the junction. One single-stranded arm, protruding ei-
ther in the 3* or 5* direction, was necessary and suffi-
cient for correct positioning of incisions by ERCC1-XPF.
Our data specify the engagement of ERCC1-XPF in NER
and allow a more direct search for its specific role in
recombination.
Nucleotide excision repair (NER)1 guards the integrity of the
genome by removing bulky adducts and the most prominent
UV-induced lesions from the DNA. During NER, the damaged
DNA strand is incised asymmetrically around the lesion to
allow release of the damage as part of a 24–32-nucleotide DNA
fragment, followed by resynthesis and ligation (1–3). Whereas
the latter steps are accomplished by general replication factors
such as proliferating cell nuclear antigen, replication factor C,
DNA polymerase d, and/or e and ligase, the incision stage of
NER requires the action of XP factors (XPA-G) (4). XPA, and
perhaps XPC complexed with hHR23B, are thought to be in-
volved in damage recognition; XPB and XPD, two helicases
present in the basal transcription factor complex TFIIH, and
replication protein A (RPA) presumably demarcate the lesion
by local opening of the DNA; XPG and the heterodimeric com-
plex ERCC1-XPF perform the actual DNA cleavage. The role of
XPE is, as yet, unclear. Mutations in either of the XP factors
can cause the extreme UV-sensitive and cancer-prone pheno-
type observed with Xeroderma pigmentosum (XP) patients.
Some human XP genes cross-complement the NER defect of
laboratory induced UV-sensitive Chinese hamster mutant cell
lines, subdivided into 10 complementation groups. Human
XPF, for example, corrects the repair-defect of rodent group 4
cell lines. The human excision repair cross-complementing
gene ERCC1 corrects rodent group 1 cell lines, but no ERCC1-
deficient patients are known. ERCC1 and XPF form an endo-
nuclease that incises the damaged strand 15–24 nucleotides
away at the 59 side of the lesion (5, 6). Cleavage by ERCC1-XPF
and XPG, which makes the 39 incision during NER, presumably
occurs in a structure-specific manner, as both NER nucleases
cut artificial DNA substrates preferentially at duplex single-
stranded junctions (6, 7). Incisions made by ERCC1-XPF and
XPG during NER co-localize to the borders of the opened DNA
intermediate (8) and protein-protein interactions with other
NER factors are likely to determine the exact positioning of
both nucleases. For ERCC1-XPF, interactions with XPA and
RPA have been reported (9–12).
The counterpart of ERCC1-XPF in Saccharomyces cerevisiae,
Rad10-Rad1, is required not only for NER but also for recom-
bination between direct repeated DNA sequences, a process
which is also called single strand annealing (13, 14). By anal-
ogy, ERCC1-XPF is expected to fulfil a similar role in mamma-
lian cells, and the two homologous protein complexes have been
proposed to remove 39 protruding single-stranded arms from
recombined duplex regions (13, 15). Chinese hamster mutant
cell lines defective in either ERCC1 (group 1) or XPF (group 4)
are unique among the other NER-deficient mutants in that
they show an extreme sensitivity to DNA cross-linking agents
such as cisplatin and mitomycin C (16). Repair of interstrand
cross-links probably also requires a recombinational event.
To gain insight in the role of ERCC1-XPF in such recombi-
national processes and in the NER reaction, it is of importance
to define its DNA substrate specificity. Similar studies with the
FEN-1 family of structure-specific nucleases revealed interest-
ing characteristics of individual members. Flap endonuclease-1
(FEN-1), implicated in both in vitro replication (17) and in vitro
repair (18), was found to cleave branched DNA structures with
59 protruding single-stranded arms (flaps, splayed arms), but
not with closed single-stranded regions (loops, bubbles) (19).
XPG, also a member of this family and as yet only known to be
involved in NER, cleaves both stem-loop and bubble substrates
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as well as flaps and splayed arms (7, 8). Similar results were
obtained with the S. cerevisiae homolog of XPG, Rad2, and all
three members of this nuclease family cleaved DNA with sim-
ilar polarity, i.e. in one strand of duplex DNA at the 39 side of
the junction with single-stranded DNA (20, 21). The differences
in substrate specificity between XPG and Rad2 on the one hand
and FEN-1 on the other, may point at their different roles in
the cell. The well defined structural DNA requirements of
FEN-1 have been the key to the recent disclosure of its role in
vitro in a base excision repair subpathway (18). ERCC1-XPF,
and its yeast homolog Rad1-Rad10, are not part of a larger
family of structure-specific nucleases. Rad1-Rad10 was previ-
ously shown to cleave flaps, splayed arms, stem-loops, and
bubbles at the 59 side of duplex single-stranded junctions (22).
Intriguingly, the sole domain shared between ERCC1 and
FEN-1 nucleases, a presumed helix-hairpin-helix motif present
twice at the C terminus of ERCC1, is lacking in Rad10 (23, 24).
This double motif, in total approximately 50 residues long, is
assumed to be involved in non-sequence specific DNA binding
(25) and might endow ERCC1-XPF with additional properties
or altered substrate specificity compared with Rad1-Rad10.
Here we report a detailed analysis of the DNA structural
elements required for ERCC1-XPF cleavage. We found that
ERCC1-XPF needs at least 4–8 unpaired nucleotides to cleave
stem-loop substrates. Single-stranded arms protruding in the
39 direction were efficiently removed by ERCC1-XPF from
splayed arm and flap substrates. Incisions occurred in duplex
DNA at the 59 side of a junction with single-stranded DNA.
Both 39 and 59 protruding arms could be used by ERCC1-XPF
for correctly positioning its nuclease activity. These data pro-
vide a framework to envisage ERCC1-XPF activity in repair as
well as in recombinational pathways.
EXPERIMENTAL PROCEDURES
Construction of Recombinant Baculoviruses—The construction of a
cDNA encoding ERCC1 with a C-terminal 6xHis-tag was described
previously (6). The 39 end (NcoI-BamHI) of this cDNA was used to
replace the 39 end (NcoI-BamHI) of wild-type ERCC1 cDNA in the
vector pET3C-ERCC1 which contains a unique NdeI site at the trans-
lation initiation site. This NdeI site and a ClaI site were used to isolate
ERCC1His cDNA, recessive ends were filled in by Klenow fragment,
and the cDNA was cloned into the blunt-ended BamHI site of the donor
plasmid pFastBacI (BAC-TO-BAC Baculovirus Expression System, Life
Technologies, Inc.), resulting in pFastBacI-ERCC1His. To introduce a
6xHis-HA epitope encoding DNA sequence at the 39 end of XPF cDNA,
first a (blunt) in-frame NruI site was introduced at the 39 end of the XPF
coding region by means of polymerase chain reaction using the ant-
isense primer 59-CGATCGATTCGGAAGCGCTGCCTCCCTTTTTCCC-
TTTTCCTTTTGAT-39. Two primers (1, HIS-HA sense: 59-CACCACCA-
TCACCATCACGGAGGCAGCGCTTACCCATAGATGTTCCAGATTAC-
GCTAGCTGAATCGATG-39; and 2, HIS-HA antisense: 59-GATCCATC-
GATTCAGCTAGCGTAATCTGGAACATCGTATGGGTAAGCGCTGC-
CTCCGTGATGGTGATGGTGGTG-39) were annealed and cloned into
the NruI site, resulting in construct pBL-XPFHisHA. This construct
was sequenced to exclude the presence of cloning and polymerase chain
reaction mistakes. An NcoI (present on translation initiation site)-ClaI
digest (both blunt-ended by Klenow fragment) released the XPF-HisHA
cDNA, which was cloned into the BamHI site (also made blunt by
Klenow fragment) of the donor plasmid pFastBacI (Life Technologies,
Inc.), resulting in construct pFastBacI-XPFHisHA. pFastBacI-
ERCC1His and pFastBacI-XPFHisHA plasmids were transfected sep-
arately into competent DH10Bac cells to allow site-specific transposi-
tion with the Bacmid bMON14272. The recombinant Bacmids (rBac-
ERCC1His and rBac-XPFHisHA) were isolated and transfected into
Sf21 cells, which resulted in the production of recombinant viruses,
designated virBac-ERCC1His and virBacXPFHisHA, respectively.
Baculovirus Infection and Extract Preparation from the Infected
Cells—Virus amplification was performed as described (instruction
manual BAC-TO-BAC system, Life Technologies, Inc.). For production
of the proteins, seven 175-cm2 dishes with monolayers of Sf21 cells were
co-infected with virBac-ERCC1His and virBacXPFHisHA, at a multi-
plicity of infection of 5–10. Two days post-infection, cells were collected
by low-speed centrifugation and washed twice with ice-cold phosphate-
buffered saline. Cell pellets were fractionated as described before (26).
Briefly, pellets were lysed in 8 times packed cell volume of NP-lysis
buffer (25 mM Tris, pH 8, 1 mM EDTA, 10% glycerol, 1% Nonidet P-40,
1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1 mg/ml aprotinin, 1
mg/mg leupeptin, and 1 mg/ml antipain), incubated on ice for 30 min,
and centrifuged at 800 3 g for 10 min. The resulting supernatant (S1),
containing most of the ERCC1-XPF complex, was used for further
purification.
Purification of Recombinant ERCC1-XPF Complex—Prior to loading,
NaCl concentration of S1 protein extracts was adjusted to 0.15 M.
Protein extracts were applied to a phosphocellulose column (1 ml of
beads per 7 mg of protein, Whatman P-11), equilibrated in buffer A (20
mM HEPES-KOH, pH 7.8, 2 mM MgCl2, 10% glycerol, 1 mM phenyl-
methylsulfonyl fluoride, 5 mM b-mercaptoethanol, 0.02% Nonidet P-40)
containing 0.15 M KCl. Bound proteins were eluted in buffer A contain-
ing 0.6 M KCl. After co-incubation of this fraction overnight at 4 °C with
Ni21-NTA-agarose (Qiagen; 1 ml/5 mg of protein) in the presence of 1
mM imidazole, the protein-beads slurry was packed in a column, which
was then washed with buffer A containing 20 mM imidazole (0.6 M KCl)
and buffer A containing 40 mM imidazole (0.1 M KCl). ERCC1 and XPF
were eluted in buffer A containing 200 mM imidazole and 0.1 mM KCl.
Insulin (0.1 mg/ml) was added and this fraction was dialyzed twice for
1 h against buffer B (20 mM HEPES-KOH, pH 7.8, 10% glycerol, 2 mM
dithiothreitol, 0.02% Nonidet P-40, 50 mM KCl, 1 mM EDTA, 2 mM
MgCl2). Typically, 50–100 mg (20 ng/ml) of purified complex was ob-
tained from 15 mg of S1 protein extract.
To analyze complex formation between ERCC1 and XPF, 200 ml of
the purified fraction was applied onto a 4.2-ml 15–35% glycerol gradient
in buffer B. The gradients were centrifuged for 20 h at 300,000 3 g and
160-ml fractions were collected.
In Vitro and in Vivo Repair Correction Assays—To test repair-cor-
recting activity in vitro, 60 ng of purified ERCC1-XPF complex was
added to Manley-type cell extracts derived from the indicated mutant
cell lines; the protein mixture was incubated with an undamaged and a
N-acetoxy-2-acetylaminofluorene-damaged plasmid in the presence of
32P-labeled deoxynucleotides. Specific 32P incorporation into the dam-
aged plasmid was used as a measure for DNA repair synthesis (for
details, see Wood et al., Ref. 27). In vivo repair activity was determined
by micro-injection of purified ERCC1-XPF into the cytoplasm of XPF
homopolykaryons (XP126LO fibroblasts) or into the cytoplasm of mouse
embryonal fibroblasts (MEFs) derived from ERCC1-deficient mice (28).
Repair activity was analyzed after 4 h by UV-induced (15 J/m2) incor-
poration of [3H]thymidine and autoradiography as described (29). The
number of grains above the nuclei is a measure of unscheduled DNA
synthesis and reflects the cellular repair capacity.
Nuclease Assays—DNA oligonucleotides were purified by denaturing
PAGE and 100–150 ng of DNA substrate was 32P-labeled using polynu-
cleotide kinase or Klenow fragment, followed by phenol extraction in
100 ml and Sepharose G-50 column centrifugation. To allow self-anneal-
ing, oligonucleotides were heated for 3 min at 95 °C and put on ice.
Labeled substrates were kept at 4 °C. For the construction of flap
substrates, one of the oligonucleotides was labeled, a 2-fold molar ex-
cess of the unlabeled complementary oligonucleotides was added, and
the mixture was heated at 95 °C for 5 min, followed by stepwise cooling
to allow annealing (30 min at 60 °C, 30 min at 37 °C, 30 min at 25 °C,
and 30 min on ice).
Nuclease reactions (15 ml) were carried out in optimized nuclease
buffer (50 mM Tris, pH 8.0, 0.2 mM MnCl2, 0.1 mg/ml bovine serum
albumin, and 0.5 mM b-mercaptoethanol), containing 100 fmol of sub-
strate DNA and 100 fmol of recombinant ERCC1-XPF complex. Reac-
tions were incubated for 90 min at 28 °C and either stopped by adding
15 ml of 90% formamide, heated at 95 °C, and loaded onto 10–20%
denaturing polyacrylamide gels, or 5% glycerol was added and samples
were immediately loaded onto 15–20% non-denaturing polacrylamide
gels. Reaction products were visualized by autoradiography or
PhosphorImager.
RESULTS
Characterization of Purified Recombinant ERCC1-XPF—To
reconstitute recombinant ERCC1-XPF protein complex, Sf21
insect cells were co-infected with ERCC1- and XPF-containing
baculovirus expression constructs. Both ERCC1 and XPF
cDNAs encoded C-terminal affinity tags, a 6xHis-tag and a
6xHis-HA-epitope double-tag, respectively, to facilitate purifi-
cation of proteins. Neither of these tags interfered with the
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function of the proteins in vivo, as micro-injection of XPF-
(6xHis-HA) cDNA into the nucleus of XPF-deficient human
fibroblasts and transfection of ERCC1-(6xHis) cDNA into
ERCC1-deficient Chinese hamster cells fully corrected the re-
pair defects of these mutant cell types (data not shown). A
three-step purification protocol, which included phosphocellu-
lose, nickel affinity chromatography, and a glycerol gradient,
resulted in highly purified fractions containing 2 major pro-
teins on silver stain with apparent molecular weight of approx-
imately 40,000 and 115,000 (Fig. 1A). Immunoblot analysis
with polyclonal antibodies confirmed these proteins to be
ERCC1 and XPF (Fig. 1B). On the glycerol gradient the major-
ity of ERCC1 and XPF was found to co-migrate, which demon-
strated that the proteins reconstitute a stable ERCC1-XPF
protein complex in insect cells. As only little further purifica-
tion was obtained with this gradient and no significant differ-
ences were detected between the enzymatic activities of Ni-
purified versus glycerol gradient-purified protein fractions,
most experiments were performed with Ni-purified proteins.
During the progress of this work also, recombinant ERCC1-
XPF was purified from Escherichia coli, which was used to
confirm that the activities described below were intrinsic to the
ERCC1-XPF complex (data not shown).
The activity of recombinant ERCC1-XPF was tested in in
vitro and in vivo repair assays. In vitro, ERCC1-XPF was found
to correct the repair-deficient phenotype of cell extracts from
human XP-F and Chinese hamster complementation groups 1
and 4, but not from XP-G (Fig. 1C). Correction was also found
with an extract from the Chinese hamster mutant cell line
UVS1, formerly known as the sole representative of comple-
mentation group 11, but recently shown to be functionally
deficient in XPF as well (6). To test the activity of recombinant
ERCC1-XPF in vivo, purified complex was micro-injected into
primary fibroblasts derived from an XP-F patient. The injected
cells showed a significant increase of unscheduled DNA syn-
thesis after UV treatment, indicative for restored NER capacity
(Fig. 1D). Chinese hamster cells are not very suitable for micro-
injection for technical reasons, but the establishment of MEFs
from a repair-deficient ERCC12 mouse (28) enabled us to an-
alyze protein fractions for ERCC1-correcting activity in vivo.
Micro-injection of purified ERCC1-XPF in these cells resulted
in a significant increase in repair activity as well (Fig. 1D).
These data demonstrate that the purified recombinant ERCC1-
XPF complex effectively supports NER both in vitro and in
vivo.
Recombinant ERCC1-XPF Incises DNA at Duplex Single
Strand Junctions—Previously, we have shown that a His-
tagged ERCC1-XPF complex purified from Chinese hamster
ovary cells efficiently incises artificial DNA substrates contain-
ing a duplex single-stranded DNA junction (6). The observed
ERCC1-XPF endonuclease activity was structure-specific and
independent of other proteins like RPA. To test nuclease activ-
ity of our recombinant ERCC1-XPF, similar assays with such
stem-loop substrates were performed. Rather than random
DNA sequences, our artificial substrates exclusively contained
thymine residues in the single-stranded regions to minimize
formation of secondary DNA structures. Two major incisions
were detected when recombinant ERCC1-XPF was applied to
these substrates, being in one strand of the duplex region, two
and three nucleotides (nt) away at the 59 side of the junction
(Fig. 2, A and B). This cleavage pattern was identical to that
observed with endogenous ERCC1-XPF purified from Chinese
hamster ovary cells (6).
To define optimal conditions for the nuclease activity we
analyzed scissions at various concentrations of divalent metal
ions. As also observed with the Chinese hamster ovary ERCC1-
XPF complex, incision activity was absolutely dependent on the
presence of divalent cations, as addition of EDTA completely
blocked incisions (Fig. 2C, lane 4). Both Mg21 and Mn21 stim-
ulated the endonuclease activity and, surprisingly, Mn21 ap-
peared to stimulate much better than Mg21. Optimal activity
was observed in low concentrations of Mn21 (0.2 mM) (Fig. 2C,
lane 14) and was approximately 3 times higher than in the
most optimal Mg21 buffer (Fig. 2C, lane 6). In contrast, incision
activity was inhibited by increasing amounts of Ca21 (lanes
9–12), showing that Ca21 cannot substitute for Mg21 and
Mn21 in these reactions. The reaction products appearing at
0.2 mM Mn21 were similar to those observed in all Mg21 buffers
tested (Fig. 2C), demonstrating that low Mn21 concentrations
were suitable for studying ERCC1-XPF activity. A control re-
FIG. 1. Characterization of purified recombinant ERCC1-XPF. A, silver-stained protein profile of the top fraction from glycerol gradient.
B, immunoblot analysis of same fraction, using anti-ERCC1 and anti-XPF antibodies. C, in vitro repair synthesis assay. Upper panels show
ethidium bromide-stained DNA, lower panels show autoradiogram of same agarose gel. 43–3B, Chinese hamster group 1 cell line; UV41, group 4
cell line; UVS1, group 4 cell line (former group 11); other cell lines originate from XP patients. G and 1 indicate that an XPG- and an
ERCC1-deficient cell extract was used for complementation, respectively. Below each lane is indicated the amount of complementation obtained
with purified ERCC1-XPF protein relative to that obtained with a complementing cell extract. Numbers were obtained by quantitation of specific
incorporation of radiolabel into the N-acetoxy-2-acetylaminofluorene-damaged plasmid (i.e. incorporation in damaged minus undamaged plasmid),
taking into account the amount of DNA present in each lane. Note that purified ERCC1-XPF complex is able to complement 43–3B and UVS1 cell
extracts, as reflected by the increased levels of incorporation into damaged DNA. D-F, in vivo repair synthesis assay. D, XPF fibroblasts (arrow
indicates injected multikaryon). E, uninjected; and F, injected ERCC1 MEFs. Nuclei were micro-injected with purified ERCC1-XPF. Number of
grains above the nuclei, used as a measure for repair capacity, was increased 5–10 times both in XPF2 primary fibroblasts and in ERCC12 MEFs
upon injection of purified ERCC1-XPF.
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action in 0.2 mM MnCl2 without ERCC1-XPF (but with a cor-
responding amount of ERCC1-XPF dilution buffer B) showed
that the DNA substrate is not subject to aspecific degradation
under these conditions (Fig. 2D, lane 1); furthermore, when the
same stem-loop substrate was labeled at the 39 end, ERCC1-
XPF cleavage at 0.2 mM Mn21 resulted in a relatively large
incision product consisting of the complete single-stranded loop
and one strand of the stem, which demonstrated the absence of
single-stranded endonucleolytic degradation (Fig. 2D, lane 3).
In view of these results, all assays described below were per-
formed in a standard buffer containing 0.2 mM MnCl2.
Minimal Loop-size Incised by ERCC1-XPF—Determination
of the minimal size of the single-stranded loop in a stem-loop
substrate can provide indications about the minimal degree of
helix opening required for ERCC1-XPF incision, a relevant
parameter for NER. To investigate this, stem-loops with vary-
ing loop and stem sizes but with a similar DNA context around
the junction were constructed (see Table I). If possible, the total
amount of nucleotides was kept the same among these sub-
strates. Incisions were observed on stems with a loop of 12, 18,
22, and 40 nucleotides, whereas a loop of 8 nucleotides only
gave minor cleavage products (Fig. 3). All incisions were made
at identical positions relative to the junction, 2 and 3 nucleo-
tides away in the stem. Occasional incisions were seen in sub-
strates with a loop size of 4 nucleotides (data not shown), but
none were found in a 2-nucleotide loop and a fully paired
hairpin structure (see also Fig. 4). This demonstrated that
DNA substrates with less than 4–8 unpaired bases become
poor DNA substrates for ERCC1-XPF mediated incision. Com-
parison of equally large stems (12 base pair) with different loop
sizes (22 versus 40 nt) showed that incision efficiency increased
with the size of the single-stranded loop (Fig. 3, lanes 4 and 5).
We could not determine the minimal duplex size requirements
for ERCC1-XPF activity as base pairing will be lost with very
small stems, but apparently a 12-base pair stem is still suffi-
cient for ERCC1-XPF mediated cleavage.
Minimal DNA Structural Elements Required for ERCC1-
XPF-mediated Incision—A role for ERCC1-XPF has been an-
ticipated not only in NER, but also in repair of interstrand
cross-links and in single-strand annealing. The DNA interme-
diates that are recognized and cut by ERCC1-XPF during these
events will probably differ from each other but they most likely
share the simplest DNA structural motif that can be cleaved by
the complex. Since the exact DNA structural elements required
for endonucleolytic activity of ERCC1-XPF are still largely
unknown, we decided to dissect the basic stem-loop substrate
as listed in Fig. 4A.
A partially self-complementary oligonucleotide with two un-
paired arms (splayed arm substrate) was incised by ERCC1-
XPF only on one side of the duplex near the junction, causing
removal of the 39 protruding single-stranded arm. The polarity
of this incision corresponded to those observed in stem-loop
substrates. Comparison to Maxam-Gilbert ladders revealed
that the major incision was made 4 nucleotides away from the
DNA junction in the stem region (Fig. 4B). To investigate
whether ERCC1-XPF required two or just one single-stranded
arm for recognition and incision, self-annealing substrates
were used having a constant duplex DNA region with either a
39 or 59 protruding single-stranded overhang (Fig. 4A). Consist-
ent with the activity of Rad1-Rad10, ERCC1-XPF was found to
remove the 39 protruding single-stranded arm by incising this
particular DNA strand in the duplex near the junction (Fig.
4C). Interestingly, incisions near the DNA junction were also
detected in the substrate containing the 59 protruding arm (Fig.
4D). In this case, cleavage did not result in removal, but rather
extension of the single-stranded portion, as incisions were
solely made in the opposite, non-protruding DNA strand. The
polarity of cleavage was again consistent with the ERCC1-
XPF-mediated incisions observed in stem-loops and splayed
arms, being in one strand of duplex DNA at the 59 side of a
duplex single-stranded junction. Since we never observed inci-
sions at blunt-ended duplex regions (for example, in the stem-
loop substrates), we concluded that one single-stranded arm,
moving away from the junction in either 39 or 59 direction, is
necessary and sufficient for ERCC1-XPF to correctly position
its nuclease activity on the DNA.
ERCC1-XPF Cleaves 39-Flap Structures—To envisage its
role in the single-strand annealing pathway, ERCC1-XPF has
been proposed to remove 39 protruding single-stranded arms
from recombined duplex regions (13). To investigate whether
ERCC1-XPF is able to cut these so-called flap structures, three
(partially) complementary oligos were mixed and annealed
(Fig. 5A). Analysis on native gels showed that this resulted in
a mixture of all possible annealing products. Therefore both
native and denaturing gels were used to analyze incisions (Fig.
5, B and C). In this way we found that ERCC1-XPF not only
FIG. 2. Recombinant ERCC1-XPF
cleaves stem-loop substrate at DNA
junction. A, incision assay with stem 12-
loop 22. Lane 1, no protein added. Lane 2,
20 ng of ERCC1-XPF. Lanes 3 and 4,
Maxam-Gilbert sequence ladders, ob-
tained from stem 21 to loop 4. Note that
59-labeled Maxam-Gilbert sequence prod-
ucts run approximately 1.5 nt faster than
ERCC1-XPF cleavage products. Asterisks
indicate position of radioactive label in
the substrate. B, schematic presentation
of ERCC1-XPF incisions in stem 12-loop
22 substrate. C, divalent cation require-
ments for ERCC1-XPF cleavage. Lanes
1–2, Maxam-Gilbert ladders. Lane 3, no
protein. Lanes 4–17, 20 ng of ERCC1-
XPF. Lane 4, 5 mM EDTA. Lanes 5–8, 1, 2,
4, and 8 mM MgCl2, respectively. Lanes
9–12, 1, 2, 4, and 8 mM CaCl2. Lanes
13–17, 0.1, 0.2, 0.5, 1, and 2 mM MnCl2. D,
absence of aspecific (single-stranded)
DNA degradation in 0.2 mM Mn21-nucle-
ase buffer. Lane 1, 59-labeled stem-loop
substrate, no ERCC1-XPF. Lane 2, 59-la-
beled stem-loop substrate with 20 ng of
ERCC1-XPF. Lane 3, 39-labeled stem-loop
substrate with 20 ng of ERCC1-XPF.
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incised the splayed arm substrates present in the mixture, but
also the proposed intermediate in single strand annealing, the
flap structure, thereby removing the 39 protruding single-
stranded arm from the duplex region. Major incisions in both
this splayed arm and flap substrate were made 7 and 8 nucle-
otides away from the junction (Fig. 5D). The flap substrate was
cleaved less efficiently than the splayed arm substrate (Fig.
5B), which shows that ERCC1-XPF prefers two single-stranded
rather than two duplex arms at a DNA junction. No release of
a single-stranded arm protruding 59 from a flap substrate was
observed, showing that also these substrates are recognized
and cleaved with a defined polarity.
DISCUSSION
ERCC1-XPF Is a Structure-specific Endonuclease—Struc-
ture-specific DNA nucleases have been implicated in a variety
of DNA metabolizing processes, including replication, recombi-
nation, and repair (30). Recently, we showed that ERCC1-XPF
purified from Chinese hamster cells specifically incised DNA at
duplex single-stranded borders, hence defining it as a struc-
ture-specific endonuclease (6). Others, however, reported that
ERCC1-XPF cleaved single-stranded DNA (31) and that RPA
confered structure-specific endonuclease activity to ERCC1-
XPF (11). Here we demonstrate that a recombinant ERCC1-
XPF complex, highly purified from insect cells, makes incisions
specifically near DNA junctions in stem-loops, splayed arms,
flaps, and single-stranded overhanging DNA substrates. Inci-
sions were found in the absence of other proteins, showing that
this activity is intrinsic to ERCC1-XPF. No scissions were
observed in the single-stranded DNA regions of our substrates.
We would like to propose two possible explanations for the fact
that we find intrinsic structure-specific endonucleolytic activity
with purified ERCC1-XPF, whereas others do not. First, by
using stretches of thymines rather than random sequences we
think we have minimized the formation of secondary structure
in the single-stranded DNA portions of the substrates. Well
defined single-stranded character was shown to be an impor-
tant parameter for optimal activity of structure-specific nucle-
ases (8). Second, to detect incisions, optimized buffer conditions
appeared to be crucial. Hardly any incisions were detectable
when reactions were performed in the presence of 10 mM Mg21,
whereas clear activity was observed with low Mg21 (1–2 mM)
and especially with low Mn21 (0.2–1 mM) concentrations. Thus,
our data firmly establish ERCC1-XPF, like its yeast homolog
Rad1-Rad10 (22), as a protein complex with intrinsic structure-
specific endonuclease activity. Concerning replication protein
A, we found that the effect of RPA on ERCC1-XPF activity was
strongly dependent on the DNA substrate used. Although RPA
was never found to be required for confering structure-specific
endonuclease activity to ERCC1-XPF, we did observe a stimu-
latory effect on the nuclease activity, specifically in those cases
where ERCC1-XPF cleavage occurred in the strand opposite
the one RPA was bound to. Conversely, RPA blocked incision
FIG. 3. Determination of the minimal single-stranded loop
size. Lanes 1–5, 20 ng of ERCC1-XPF added. Lane 1, stem 19-loop 8.
Lane 2, stem 17-loop 12. Lane 3, stem 14-loop 18. Lane 4, stem 12-loop
22. Lane 5, stem 12-loop 40.
TABLE I
Artificial DNA substrates
Nucleotides denoted in small letter type were filled-in by DNA polymerase I Klenow fragment, optionally with radioactive labeled dNTPs. Sizes
of duplex regions are in base pairs, sizes of loops and overhangs in nucleotides. For the 39-flap and 59-flap, the oligonucleotide composition is given.
Underlined sequences in F32 and F30 represent unpaired protruding arms.
ERCC1-XPF in Recombination and Repair 7839
 at Erasm
us M
C M
edical Library on O
ctober 23, 2006 
w
w
w
.jbc.org
D
ow
nloaded from
 
activities that were directed to the same strand it was bound to.
Details on this intricate cross-talk between RPA and ERCC1-
XPF will be published elsewhere.
Comparison with Other Structure-specific Nucleases—An ex-
tensively studied family of structure-specific nucleases is the
FEN-1 family. Its members, which include the repair proteins
Rad2 in S. cerevisiae and mammalian XPG, share three large
stretches of homologous amino acids with FEN-1 (20). Like
ERCC1-XPF, these enzymes cleave branched DNA structures,
but they do this at the opposite side of the junction, where the
single-stranded DNA is moving away in a 39 to 59 direction (7,
19). Consistent with this cleavage polarity, XPG has been
shown to make the 39 incision during NER (7). Although FEN-1
and XPG act similarly on certain DNA structures (flaps,
splayed arms), distinct activities on other DNA substrates hint
at their different activities in the cell. For example, FEN-1
prefers flap substrates and does not cleave bubble substrates
nor other substrates with a closed loop, which probably reflects
the requirement of free single-stranded DNA ends for FEN-1
DNA-binding (19, 32). Also, no FEN-1 incisions were observed
in substrates containing one single-stranded overhang, show-
ing that FEN-1 only cleaves certain types of single-stranded
duplex DNA junctions. A functional relevance for FEN-1-me-
diated incisions was recently provided with the finding that
completion of a subpathway of DNA base excision repair in
vitro requires FEN-1-dependent removal of splayed arm inter-
mediates; XPG could not substitute for FEN-1 in this reaction
(18).
As the engagement of ERCC1-XPF in recombinational
events is still poorly understood, it is of particular importance
to define the DNA substrate specificity of this protein complex.
On the amino acid sequence level, ERCC1 shares a relatively
small region of homology with FEN-1 and XPG, encompassing
a helix-hairpin-helix motif. This motif, present twice in
ERCC1, has been implicated in non-sequence-specific DNA
binding (25). Functionally, the ERCC1-XPF complex is most
FIG. 5. ERCC1-XPF cleaves 3*-flap substrates. A, denaturing
PAGE analysis of 39-flap incisions. B, native PAGE analysis of 39-flap
incisions. For A and B: lane 1, 39-flap, F17 radiolabeled, no protein.
Lane 2, 39-flap, F17 labeled, 20 ng of ERCC1-XPF. Lane 3, 39-flap,
F32-labeled, no protein. Lane 4, 39-flap, F32 labeled, 20 ng of ERCC1-
XPF. Lane 5, splayed arm, F32 labeled, no protein. Lane 6, splayed arm,
F32 labeled, 20 ng of ERCC1-XPF. Note that especially splayed arm
substrate shows a heterogeneous migration pattern on native PAGE (B,
lanes 3 and 5). C, determination of exact cleavage positions. Lanes 1 and
2, Maxam-Gilbert ladders of F32. Lane 3, ERCC1-XPF cleavage pattern
of 39-flap, F32 radiolabeled. D, schematic presentation of ERCC1-XPF
incisions in 39-flap substrates.
FIG. 4. Minimal DNA structural elements required for ERCC1-XPF activity. A, schematic presentation of “dissected” stem-loop substrate.
B, splayed arm substrate, 59 radiolabeled. C, 39-overhang substrate, 59 radiolabeled. D, 59-overhang substrate, 39 radiolabeled. For each panel
(B-D): lane 1, no protein added. Lane 2, 20 ng of ERCC1-XPF. Lanes 3 and 4, Maxam-Gilbert ladders of corresponding substrate; counting starts
at junction (note that in C, the 39-overhang substrate, separation of Maxam-Gilbert ladders is insufficient to exactly determine cleavage positions).
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readily compared with XPG. Like XPG, and perhaps expected
from its involvement in NER, ERCC1-XPF efficiently cuts bub-
ble substrates (6) and stem-loops, demonstrating that these
NER nucleases do not require free single-stranded DNA ends
for their activities. We found that ERCC1-XPF incises splayed
arms and flaps, thereby cleaving off the 39 protruding single-
stranded arm in each case. ERCC1-XPF incisions were also
observed in substrates with a 39 or a 59 overhanging arm only,
resulting in removal or extension of the single-stranded por-
tion, respectively. In contrast to FEN-1, we found that also
XPG incised these substrates, and in agreement with its re-
ported cleavage polarity, this caused extension of the 39 arm
and removal of the 59 arm, respectively (data not shown).
Apparently, contribution of DNA breathing in these cases is
limited and the observed incision activities of ERCC1-XPF and
XPG are specific for these overhanging substrates, as we could
not detect comparable incisions at the blunt-ended duplex DNA
of, for example, stem-loop substrates. Thus, a junction with one
single-stranded arm, branching away from duplex DNA either
in the 39 or the 59 direction, is necessary and sufficient for
correct positioning of incisions by ERCC1-XPF and XPG. We
postulate that in S. cerevisiae, the same will hold for Rad2 and
Rad1-Rad10. The latter complex was previously shown to cut
branched DNA substrates (22), but an activity on 59 overhang-
ing substrates has not been reported yet. Intriguingly, Rad10
lacks the helix-hairpin-helix motif that ERCC1 shares with
other structure-specific nucleases. As the substrate specificities
of ERCC1-XPF and Rad1-Rad10 appear to be similar, either
this motif is not absolutely required for structure-specific nu-
clease activity, or alternatively, it is cryptically present else-
where in the Rad1-Rad10 complex.
Incision Position Partially Depends on DNA Sequence—Run-
ning Maxam-Gilbert sequence ladders along our assays al-
lowed a detailed analysis of the cleavage patterns. ERCC1-
XPF-mediated incisions always occurred in the duplex some
nucleotides away from the junction, varying from 2 to 3 nucle-
otides in stem-loop substrates, to 7–8 nucleotides in the case of
the flap substrate. Given the fact that the DNA sequence
around the junction was identical for the different stem-loop
substrates, the observation that changing the structural prop-
erties by altering loop and stem sizes did not affect the cleavage
pattern, may indicate that the site of cleavage is to some extent
sequence-dependent. In support of this notion, the splayed arm
and the flap substrates, composed of the same oligonucleotides,
were also cleaved at identical positions (see Fig. 5). A splayed
arm substrate with a different sequence composition around
the junction was cleaved at 3 nt, rather than 7–8 nt, away from
the junction (see Fig. 4). In all these cases, the major incisions
were made at the 39 side of a pyrimidine residue, suggesting
that ERCC1-XPF prefers to cleave at cytosines and thymines.
Two major incisions were observed with the 59 overhanging
substrate, one at a pyrimidine and the other at a purine resi-
due. Whether the latter incision shows that the suggested
pyrimidine preference is less strict in substrates with one sin-
gle-stranded arm only or that this preference is based on coin-
cidence, remains to be investigated.
ERCC1-XPF in Nucleotide Excision Repair—During NER,
the two incisions around the lesion are made in a near synchro-
nous manner. Several reports suggest that they occur in an
ordered fashion, with most likely the 39 (XPG-mediated) inci-
sion being made prior to the 59 (ERCC1-XPF-mediated) incision
(3, 33, 34). Depending on the type of lesion, XPG incisions have
been found 2–9 nucleotides away from the lesion, whereas
ERCC1-XPF cuts appear 15–24 nucleotides away on the oppo-
site side of the lesion (3, 33, 35). The positions of these incisions
correspond to the borders of the open DNA complex, which is
formed during NER and spans approximately 25 nucleotides
across the lesion (8). The question why such a relatively large
region is unwound and excised is still unanswered, but one
possibility could be that the size of the open complex reflects
the minimal amount of unwinding required for XPG and
ERCC1-XPF cutting activity. We found, however, that ERCC1-
XPF incised substrates with loops as small as 4–8 nucleotides.
Also XPG was previously shown to require only 5–10 unpaired
nucleotides for efficient cleavage (8). Therefore, most likely
other repair factors determine the actual size of the excised
patch and they may do so by positioning the nucleases onto the
borders of the unwound DNA intermediate. For ERCC1-XPF,
two obvious candidates are the lesion-recognizing protein XPA
and the single-stranded binding protein RPA, which both in-
teract with this nuclease complex (9–12). The fact that the size
of the patch (24–32 nt) strongly correlates to the length of the
optimal single-stranded binding region of RPA (30 nt) (36) also
suggests an important role of RPA in positioning the NER
incisions.
ERCC1-XPF in Recombinational Pathways—ERCC1-XPF
and its homologs have been implicated in such diverse proc-
esses as mating type switching in Schizosaccharomyces pombe
(37) and DNA interstrand cross-link repair in mammals. It has
been suggested that common recombinational mechanisms un-
derly these processes. Direct evidence for a role of ERCC1-XPF
in recombination comes from studies in S. cerevisiae, where it
was shown that strains defective in Rad1 or Rad10 failed to
complete recombination between direct DNA repeats, presum-
ably due to their inability to remove nonhomologous DNA from
the 39 ends of recombined DNA intermediates (13). Here we
tested directly whether ERCC1-XPF was able to remove pro-
truding DNA sequences from duplex regions and found that the
complex, like Rad1-Rad10, can indeed cut flap substrates with
single-stranded arms protruding in the 39 direction. The rele-
vance of investigating the role of ERCC1-XPF in processes
other than NER becomes most apparent from studies on
ERCC1-deficient mice. On top of the classic NER-deficient phe-
notype observed with XPA-, as well as XPC-knock-out mice,
characterized most profoundly by photosensitivity and predis-
position to UV-induced skin cancer, ERCC1-deficient mice suf-
fer from liver, spleen, and kidney abnormalities, developmental
delay, reduced life span, and signs of premature senescence
(28, 38). Accumulation of endogenously generated interstrand
cross-links has been proposed to underly these non-NER-spe-
cific clinical manifestations (28). Whether flap structures are
intermediates in, for example, interstrand cross-link repair
remains to be shown, but the DNA substrate specificity de-
scribed in this paper will allow a more direct search for the role
of ERCC1-XPF in recombinational events.
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